Last reviewed · How we verify
pentolonium
pentolonium is a drug. It is currently in unknown development.
Pentolinium is a small molecule that acts as a nicotinic acetylcholine receptor antagonist. It is used as an antihypertensive drug, particularly during surgery or to control hypertensive crises.
At a glance
| Generic name | pentolonium |
|---|---|
| Target | Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor; alpha3/beta4 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pentolonium CI brief — competitive landscape report
- pentolonium updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about pentolonium
What is pentolonium?
pentolonium is a pharmaceutical drug.
What development phase is pentolonium in?
pentolonium is in unknown.
What does pentolonium target?
pentolonium targets Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor; alpha3/beta4.
Related
- Target: All drugs targeting Neuronal acetylcholine receptor subunit alpha-10, Neuronal acetylcholine receptor; alpha3/beta4
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing